Evidence map›Paper›PMID 37274299›Full record

ArticleTherapeutic advances in gastroenterology2023

Artificial intelligence in endoscopic ultrasonography: risk stratification of gastric gastrointestinal stromal tumors.

Yi Lu, Lu Chen, Jiachuan Wu, Limian Er, Huihui Shi, Weihui Cheng, Ke Chen, Yuan Liu, Bingfeng Qiu, Qiancheng Xu and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Therapeutic advances in gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07078136 (Multicenter Observational Study of a Multimodal AI Model Using EUS, White-Light Endoscopy, and Clinical Data for Diagnosis of Upper GI Mesenchymal Tumors and Risk Stratification of Gastric GISTs), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07078136 recruitingnot on this mapstarted 2025, after this paper: background citation

Multicenter Observational Study of a Multimodal AI Model Using EUS, White-Light Endoscopy, and Clinical Data for Diagnosis of Upper GI Mesenchymal Tumors and Risk Stratification of Gastric GISTs

TypeobservationalSponsorHuazhong University of Science and TechnologyRan2025 to 2026Enrolled130ConditionsSubmucosal Tumor, Gastrointestinal Stromal Tumor (GIST), Leiomyoma, SchwannomaArmsMultimodal AI Model, Expert Endoscopist Assessment
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Applications of artificial intelligence in gastroscopy: a narrative review.The Journal of international medical research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Yi LuDepartment of Gastrointestinal Endoscopy, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.ORCID https://orcid.org/0000-0003-3979-5421
Lu ChenDepartment of Internal Medicine, Advent Health Palm Coast, Palm Coast, FL, USA.
Jiachuan WuDigestive Endoscopy Center, Guangdong Second Provincial General Hospital, Guangzhou, People's Republic of China.
Limian ErDepartment of Endoscopy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Huihui ShiDepartment of Endoscopy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Weihui ChengDepartment of Gastroenterology, Yangjiang Hospital of Traditional Chinese Medicine, Yangjiang, People's Republic of China.
Ke ChenDepartment of Endoscopy, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Yuan LiuDepartment of Endoscopy, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Bingfeng QiuDepartment of Gastroenterology, Zhoushan Hospital of Zhejiang Province, Zhoushan, People's Republic of China.
Qiancheng XuDepartment of Gastroenterology, Zhoushan Hospital of Zhejiang Province, Zhoushan, People's Republic of China.
Yue FengTianjin Economic-Technological Development Area (TEDA) Yujin Digestive Health Industry Research Institute, Tianjin, People's Republic of China.
Nan TangTianjin Center for Medical Devices Evaluation and Inspection, Tianjin, People's Republic of China.
Fuchuan WanTianjin Economic-Technological Development Area (TEDA) Yujin Artificial Intelligence Medical Technology Co, Ltd, Tianjin, People's Republic of China.
Jiachen SunDepartment of Gastrointestinal Endoscopy, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, 26 Yuancun Erheng Road, Guangzhou 510655, People's Republic of China.ORCID https://orcid.org/0000-0003-3646-1039
Min ZhiDepartment of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, 26 Yuancun Erheng Road, Guangzhou 510655, People's Republic of China.
Sun Yat-sen University · CNFudan University Shanghai Cancer Center · CNHebei Medical University · CNTianjin Economic-Technological Development Area · CNZhoushan Hospital · CNGuangdong Provincial People's Hospital · CNQujiang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous studies have identified useful endoscopic ultrasonography (EUS) features to predict the malignant potential of gastrointestinal stromal tumors (GISTs). However, the results of the studies were not consistent. Artificial intelligence (AI) has shown promising results in medicine. Objectives: We aimed to build a risk stratification EUS-AI model to predict the malignancy potential of GISTs. Design: This was a retrospective study with external validation. Methods: We developed two models using EUS images from two hospitals to predict the GIST risk category. Model 1 was the four-category risk EUS-AI model, and Model 2 was the two-category risk EUS-AI model. The diagnostic performance of the models was validated with external cohorts. Results: A total of 1320 images (880 were very low-risk, 269 were low-risk, 68 were intermediate-risk, and 103 were high-risk) were finally chosen for building the models and test sets, and a total of 656 images (211 were very low-risk, 266 were low-risk, 88 were intermediate-risk, and 91 were high-risk) were chosen for external validation. The overall accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for the four-category risk EUS-AI model in the external validation sets by tumor were 74.50%, 55.00%, 79.05%, 53.49%, and 81.63%, respectively. The accuracy, sensitivity, specificity, PPV, and NPV for the two-category risk EUS-AI model for the prediction of very low-risk GISTs in the external validation sets by tumor were 86.25%, 94.44%, 79.55%, 79.07%, and 94.59%, respectively. Conclusion: We developed a EUS-AI model for the risk stratification of GISTs with promising results, which may complement current clinical practice in the management of GISTs. Registration: The study has been registered in the Chinese Clinical Trial Registry (No. ChiCTR2100051191).

Indexed as

Artificial intelligenceendoscopic ultrasonographygastricgastrointestinal stromal tumorsrisk

Identifiers

PMID37274299
PMCPMC10233610
OpenAlexW4379376459

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.